2H2022 | Second half of the year 2022 |
AbTAC | Antibody-based PROTAC |
AD | Atopic dermatitis |
ADMET | Absorption, distribution, metabolism, excretion and toxicity |
AGA | Androgenetic alopecia |
AhR | Aryl hydrocarbon receptor |
AID | Auxin-inducible degron |
ALK | Anaplastic lymphoma kinase |
AML | Acute myeloid leukemia |
AR | Androgen receptor |
ASGPR | Asialoglycoprotein receptor |
ASO | Antisense oligonucleotide |
aTAG ATP |
AchillesTag Adenosine triphosphate |
ATTEC | Autophagy tethering compound |
AUTAC | Autophagy targeting chimera |
AUTOTAC | Autophagy targeting chimera |
Bcl | B-cell lymphoma |
BCL-xL | B-cell lymphoma-extra large |
BCR | Breakpoint cluster region protein |
BET | Bromo- and extra-terminal family |
BIAC | Bispecific aptamer chimera |
BRAF | V-raf murine sarcoma viral oncogene homolog B1 |
BRD | Bromodomain-containing protein |
BTK | Bruton’s tyrosine kinase |
CAR | Chimeric antigen receptor |
CDC20 | Cell division cycle 20 |
CDK | Cyclin-dependent kinase |
Cer | Ceritinib |
cIAP | Cellular inhibitor of apoptosis |
CI-M6PR | Cation-independent mannose-6-phosphonate receptor |
CK1α | Casein kinase 1α |
CK2 | Casein kinase 2 |
CLIPTAC | In-cell-click-formed proteolysis targeting chimera |
CLL | Chronic lymphocytic leukemia |
CMA | Chaperone-mediated autophagy |
CPP-LSS | Cell-penetrating peptide and lysosome-sorting sequence |
CRABP I/II | Cellular retinoic acid-binding protein 1/2 |
CRBN | Cereblon |
CREPT | Cell cycle-related and expression elevated protein in tumor |
CRISPR | Clustered regularly interspaced short palindromic repeats |
CT | Computed tomography |
CYP1B1 DCAF5 |
Cytochrome p450 family 1 subfamily B member 1 DDB1 and CUL4 associated factor 5 |
DCAF | DDB1 and CUL4 associated factor |
DHODH | Dihydroorotate dehydrogenase |
DHX36 | DEAH-box-protein 36 |
DLBCL DNA |
Diffuse large B cell lymphoma Deoxyribonucleid acid |
dsDNA | Double-stranded DNA |
dTAG | Degrader tag |
DUB | Deubiquitinating enzyme |
DUBTAC | Deubiquitinase-targeting chimera |
eEF2K | Eukaryotic elongation factor 2 kinase |
EGFR | Epidermal growth factor receptor |
eIF4E | Eukaryotic initiating factor 4E |
EML4 | Echinoderm microtubule-associated protein-like 4 |
ER | Estrogen receptor |
ErbB3 | Erb-b2 receptor tyrosine kinase 3 |
ERK | Extracellular signal-regulated kinase |
ESR1 | Estrogen receptor 1 |
EZH2 | Enhancer of zeste homolog 2 |
FAK | Focal adhesion kinase |
FDA | Food and drug administration |
FEM1B | Feminization-1 homolog b |
FKBP | FK506-binding proteins |
FLT3 | Fms-like tyrosine kinase 3 |
FOXO1 GlueTAC |
Forkhead box protein O1 GlueBody Chimera |
GNPs | Gold nanoparticles |
GPD1L | Glycerol-3-phosphate dehydrogenase 1 like protein |
GREB1 | Growth regulating estrogen receptor binding 1 |
GSTP1 G4 |
G1 to S phase transition 1 G-quadruplex |
HDAC | Histone deacetylase |
HECT | Homology to E6AP C terminus |
HER | Human epidermal growth factor receptor |
HIF-1-alpha | Hypoxia-inducible factor 1-alpha |
HIP1R | Huntingtin-interacting protein 1–related |
HPK1 | Hematopoietic progenitor kinase 1 |
HS HyT IAP |
Hidradenitis suppurativa Hydrophobic tagging Inhibitors of apoptosis protein |
IDO1 | Indoleamine 2,3-dioxygenase 1 |
IGF-1R | Insulin-like growth factor 1 receptor |
IKZF | IKAROS zinc finger family |
IMiD | Immunomodulatory drug |
IND | Investigational new drug |
IRAK4 | Interleukin-1 receptor-associated kinase 4 |
ITK IV |
Interleukin-2-inducible T-cell kinase Intravenous injection |
JAK | Janus kinase |
JAMM | Jab1/MPN domain-associated metallopeptidase |
KEAP1 | Kelch-like ECH associated protein 1 |
LC3 | Microtubule-associated protein 1A/1B-light chain 3 |
LD | Lipid droplets |
LEF1 | Lymphoid enhancer binding factor 1 |
LGL | Large granular lymphocyte |
LHRH | Luteinizing hormone-releasing hormone |
LIR | LC3-interacting region |
LTR | Lysosomal targeted receptor |
LYTAC | Lysosome targeting chimera |
MCL | Mantle cell lymphoma |
Mcl-1 | Myeloid cell leukemia-1 |
MCPIP | Monocyte chemotactic protein-induced protein |
mCRPC | Metastatic castration-resistant prostate cancer |
MDM2 | Mouse double minute 2 |
MEK | Mitogen-activated protein kinase kinase |
Met | Mesenchymal epithelial transition |
mHTT | Mutant huntingtin |
MINDY | Motif interacting with Ub-containing novel DUB family |
miR-96 | MicroRNA 96 |
MJD | Machado–Joseph disease protein domain |
MM | Multiple myeloma |
MoDE-A | Molecular degrader of extracellular proteins through the ASGPR |
MRI | Magnetic resonance imaging |
MTH1 | MutT homolog-1 |
MyD88 | Myeloid differentiation primary response 88 |
NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
NHL | Non-Hodgkin’s lymphoma |
NRAS | Neuroblastoma RAS viral oncogene homolog |
NSCLC | Non-small cell lung cancer |
NTRK | Neurotrophic tyrosine receptor kinase |
NVOC | Nitroveratryloxycarbonyl |
OTU | Ovarian tumor protease |
PARP1 | Poly [ADP-ribose] polymerase 1 |
PB1 | Phox and Bem1 domain |
PDE | Phosphodiesterase |
PD-L1 | Programmed death-ligand 1 |
PDX | Patient derived xenograft |
PEG | Polyethylene glycol |
PHOTAC | Photochemically targeting chimera |
PI3K | Phosphoinositide 3-kinases |
PLK1 PO |
Polo-like kinase 1 Per os |
POI | Protein of interest |
POLY-PROTAC | Polymeric PROTAC |
Pom | Pomalidomide |
PR | Progesterone receptor |
PRC | Polycomb repressive complex |
PRMT5 | Protein arginine methyltransferase 5 |
PROTACs | Proteolysis targeting chimeras |
PTB | Phosphotyrosine-binding |
PTK-7 | Protein kinase-like 7 |
R/R | Relapsed/refractory |
RAS | Rat sarcoma |
RBFOX1 | RNA binding Fox-1 homolog 1 |
RBM23 | RNA binding motif protein 23 |
RBM39 | RNA binding motif protein 39 |
RBP | RNA binding protein |
RBR | RING-between-RING |
RHAU | RNA helicase associated with AU-rich element |
RIBOTAC | Ribonuclease Targeting chimera |
RING | Really interesting new gene |
RIPK2 RNA |
Receptor interacting serine/threonine kinase 2 Ribonucleic acid |
RNF | RING finger protein |
RTK SC |
Receptor tyrosine kinase Subcutaneous injection |
SCLC | Small cell lung cancer |
SERD | Selective estrogen receptor degrader |
SGK | Serum/glucocorticoid regulated kinase family member |
SH2 | Src homology 2 |
SHP2 | Src homology 2 domain containing protein tyrosine phosphatase-2 |
siRNA | Small interfering RNA |
SirT2 | Sirtuin 2 |
SLC9A1 | Solute carrier family 9 member A1 |
SLE | Systemic lupus erythematosus |
SLL | Small lymphocytic lymphoma |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily B, member 1 |
SNIPER | Specific and non-genetic inhibitors of apoptosis protein (IAP)-dependent protein eraser |
SPAAC | Strain-promoted azide–alkyne cycloaddition |
SRC-1 | Steroid receptor coactivator-1 |
STAT3 | Signal transducer and activator of transcription 3 |
TACC3 | Transforming acidic coiled-coil containing protein 3 |
TBK1 | TANK-binding kinase 1 |
TCF | T-cell factor |
TCL | T-cell lymphomas |
TCO | Trans-cyclooctene |
TF | Transcription factor |
TFF | Trefoil factor |
TGF-β1 | Transforming growth factor beta 1 |
TI | Tumor-infiltrating |
TOI | Transcription factor of interest |
TPD | Targeted protein degradation |
TPS | Targeted protein stabilization |
TRAFTAC | Transcription factor targeting Chimera |
Treg | Regulatory T cell |
TRIM24 | Tripartite motif containing 24 |
TrkA | Tropomyosin receptor kinase A |
TZ | Tetrazine |
Ub | Ubiquitin |
UCH | Ubiquitin C-terminal hydrolase |
UPS | Ubiquitin-proteasome system |
USP | Ubiquitin-specific protease |
UV | Ultraviolet |
VEGFR | Vascular endothelial growth factor receptor |
VHL | Von Hippel-Lindau |
WM | Waldenström macroglobulinaemia |
XIAP | X-linked inhibitor of apoptosis protein |
ZUFSP | Zn-finger and UFSP domain protein |
α1A-AR | Alpha-1A adrenergic receptor |